New Metric Predicts the Likelihood of Amyloid Presence and Leads the Way in Early Alzheimer’s Detection
Novel Cognivue CARM Score Feature Now Available on Cognivue Clarity Device; Marks Milestone in Alzheimer’s Early Detection Research
May 14, 2025
Neuroscience technology innovator Cognivue®, today announced a scientific breakthrough with the launch of the Cognivue Amyloid Risk Measure (CARM)*, a novel metric that predicts the likelihood of the presence of amyloid—a key biomarker of Alzheimer’s disease (AD). Now...
May 14, 2025
Neuroscience technology innovator Cognivue®, today announced a scientific breakthrough with the launch of the Cognivue Amyloid Risk Measure (CARM)*, a novel metric that predicts the likelihood of the presence of amyloid—a key biomarker of Alzheimer’s disease (AD). Now...
New Metric Predicts the Likelihood of Amyloid Presence and Leads the Way in Early Alzheimer’s Detection
Novel Cognivue CARM Score Feature Now Available on Cognivue Clarity Device; Marks Milestone in Alzheimer’s Early Detection Research
May 14, 2025
Neuroscience technology innovator Cognivue®, today announced a scientific breakthrough with the launch of the Cognivue Amyloid Risk Measure (CARM)*, a novel metric that predicts the likelihood of the presence of amyloid—a key biomarker of Alzheimer’s disease (AD). Now...
May 14, 2025
Neuroscience technology innovator Cognivue®, today announced a scientific breakthrough with the launch of the Cognivue Amyloid Risk Measure (CARM)*, a novel metric that predicts the likelihood of the presence of amyloid—a key biomarker of Alzheimer’s disease (AD). Now...

